Boyraz, B. Et Al. 2013. Trastuzumab emtansine (T-DM1) for HER2-positive breast cancer. CURRENT MEDICAL RESEARCH AND OPINION , vol.29, no.4 , 405-414.

Boyraz, B., Sendur, M. A. N., AKSOY, S., BABACAN, T., Roach, E. C., KIZILARSLANOĞLU, M. C., ... Petekkaya, I.(2013). Trastuzumab emtansine (T-DM1) for HER2-positive breast cancer. CURRENT MEDICAL RESEARCH AND OPINION , vol.29, no.4, 405-414.

Boyraz, Baris Et Al. "Trastuzumab emtansine (T-DM1) for HER2-positive breast cancer," CURRENT MEDICAL RESEARCH AND OPINION , vol.29, no.4, 405-414, 2013

Boyraz, Baris Et Al. "Trastuzumab emtansine (T-DM1) for HER2-positive breast cancer." CURRENT MEDICAL RESEARCH AND OPINION , vol.29, no.4, pp.405-414, 2013

Boyraz, B. Et Al. (2013) . "Trastuzumab emtansine (T-DM1) for HER2-positive breast cancer." CURRENT MEDICAL RESEARCH AND OPINION , vol.29, no.4, pp.405-414.

@article{article, author={Baris Boyraz Et Al. }, title={Trastuzumab emtansine (T-DM1) for HER2-positive breast cancer}, journal={CURRENT MEDICAL RESEARCH AND OPINION}, year=2013, pages={405-414} }